Biobank of the Bashkir State Medical University, Ufa, Russia, Russia

Registration Status: Completed

Objective: The biobank of the Bashkir State Medical University is located on the basis of the University Clinic - it is a multidisciplinary medical institution of the federal level, where the three components of a medical university - education, science and medical work - are integrated for the benefit of maintaining the health of the population. The BSMU clinic has 755 beds of various profiles. The activity of Biobank BSMU is to collect, catalog and store biological samples and related clinical data. The collection of biological material is continuously replenished, blood and tissue samples of various nosologies - oncological, cardiovascular diseases and others, extensive research work is being carried out. During the spread of the new coronavirus infection (Covid-19) Biobank BSMU accumulates and systematizes the biological material of patients who have undergone this disease. Within the framework of this project, the features of the pathogenesis of coronavirus infection are studied, the mechanisms of the reaction of immune cells are studied, and the development and testing of means for the prevention, diagnosis and treatment of coronavirus infection.

Registered Biobank Name	Biobank of the Bashkir State Medical University, Ufa, Russia
Biobank Leader	Ildar Kabirov
Country	Russia
Email for biobank inquiries	ildarkabirov@gmail.com
Principal Investigator	Ildar Kabirov
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).